http://www.crinetics.com
Crinetics Pharmaceuticals, Inc. Company Intro
About: Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. We have assembled a seasoned team with extensive expertise in drug discovery and development in endocrine G-protein coupled receptors (GPCRs) and built a highly productive drug discovery organization.
Industry
Healthcare
Crinetics Pharmaceuticals, Inc. Headquaters
Building No. 2
San Diego,92121
United States
Crinetics Pharmaceuticals, Inc. Share price
22 Oct 2020 01:25 GMT
$14.96
-0.04 (-0.27 %)
Crinetics Pharmaceuticals, Inc. Market cap
$465.303 M
WMC RANKING
2020
Crinetics Pharmaceuticals, Inc. # 233
BiotechnologyLatest Crinetics Pharmaceuticals, Inc. News
21 Oct 2020
Somatostatin Receptor Type 4 Market Size, Share, Scope ...
Crinetics Pharmaceuticals Inc; Strongbridge Biopharma plc. The final report will add the analysis of the impact of Covid-19 in this Somatostatin Receptor Type 4 ...
22 Oct 2020
Polycystic Ovary Syndrome Treatment Market Size, Share ...
Addex Therapeutics Ltd. Biocad; Merck Kgaa; Astrazeneca Plc. Bristol Myers Squibb Co. Ferring Pharmaceuticals; Inc. Crinetics Pharmaceuticals; Inc. The ...
22 Oct 2020
Global Age Related Macular Degeneration Drug Market 2020 ...
... Technologies Corp, Astellas Pharma Inc, Benitec Biopharma Ltd, Biokine Therapeutics Ltd, Crinetics Pharmaceuticals Inc, Critical Pharmaceuticals Ltd, ...
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| Crinetics Pharmaceuticals, Inc. | 0.02 | 1.79 | 0.48 | 0 | 0 | 0 | 2.01 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.19 | 100 | 0 | 0 | 0 | 100 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 4.12 | 0 | 0 | 0 | 91.99 |
| 3SBio Inc. | 96.05 | 0 | 0 | 0 | 0 | 0 | 0 |
| Incyte Corporation | 40.27 | 14.26 | 7.26 | 0 | 0 | 0 | 19.01 |
Crinetics Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Crinetics Pharmaceuticals, Inc. | $1,193 | $55,025 | $-50,422 | $465.303M | 233 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $25.904B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $55.058B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.953B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.377B | 4 |